McCormick & Co. (NYSE:MKC | MKC Price Prediction) is navigating a pivotal moment: Barclays cut its price target on the spice and seasoning giant to $58 from $67 while maintaining an Equal Weight rating, citing two forces that will dominate the near-term narrative. With the stock trading near $53.72, the revised target still implies modest upside, but the path there runs through real uncertainty.
So far this year, shares are down more than 20%, and over the past year, MKC has lost nearly 35%.
| Ticker | Company | Firm | Old → New Rating | New Price Target | One-Line Takeaway |
|---|---|---|---|---|---|
| MKC | McCormick & Co. | Barclays | Equal Weight → Equal Weight | $58 | Target cut to $58 on acquisition uncertainty and Iran war cost exposure |
The Analyst’s Case
Barclays trimmed its target ahead of McCormick’s fiscal Q1 2026 earnings, arguing that updates around the potential acquisition of Unilever’s food division and a quantification of potential costs stemming from the Iran war “will take center stage.” The firm maintains its Equal Weight rating while signaling that valuation clarity depends on answers to questions that don’t yet have definitive price tags. That’s a reasonable posture given the scale of what’s potentially on the table.
Company Snapshot & Recent Performance
McCormick’s fiscal Q1 2026 results, reported this morning, came in ahead of expectations. Revenue reached $1,873.9 million against an estimate of $1,788.6 million, a beat of 4.77%, with YoY growth of 16.72%. The Consumer segment drove much of that, posting $1,145.0 million in revenue, up 24.5% year over year. Adjusted EPS came in at $0.66, and adjusted operating margin expanded 30 basis points to 14.3%.
The headline growth, however, leans heavily on the McCormick de Mexico acquisition completed in January 2026, which contributed 12.4 percentage points to the YoY revenue increase. Organic growth was a more modest 1.2%, and volume/mix was slightly negative at -0.7%. Operating cash flow also declined sharply, falling to $50.9 million from $115.5 million in the prior-year period.
The stock has been under significant pressure, down 21.13% year to date and 32.32% over the past year. It now sits near its 52-week low of $51.29.
Why the Move Matters Now
McCormick reaffirmed full-year guidance calling for net sales growth of 13% to 17% and adjusted EPS of $3.05 to $3.13. But the tax rate is rising to approximately 24% versus 21.5% in 2025, and net interest expense is climbing with the Mexico acquisition debt load. The Street consensus target sits at $67.77, well above Barclays’ revised $58, suggesting the firm is the most cautious voice in the room right now.
What Investors Should Watch
McCormick’s 40 consecutive years of dividend increases and a $0.48 per share quarterly dividend provide a floor for income-focused investors. But the Unilever food division acquisition talks introduce meaningful complexity. CEO Brendan Foley noted that “we are pleased to begin the year with first quarter results that demonstrate the strength and resilience of our business,” yet the macro and deal-related unknowns are real. Acquisition clarity and organic volume recovery are the two signals most likely to shift the valuation narrative.